Skip to main content
NCBI home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1997 Feb;50(1):1–3. doi: 10.1136/mp.50.1.1

Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

K Cooper 1, J O McGee 1
PMCID: PMC379570  PMID: 9208805

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berumen J., Unger E. R., Casas L., Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol. 1995 Jun;26(6):676–681. doi: 10.1016/0046-8177(95)90175-2. [DOI] [PubMed] [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  3. Brinton L. A. Epidemiology of cervical cancer--overview. IARC Sci Publ. 1992;(119):3–23. [PubMed] [Google Scholar]
  4. Campion M. J., McCance D. J., Cuzick J., Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet. 1986 Aug 2;2(8501):237–240. doi: 10.1016/s0140-6736(86)92067-2. [DOI] [PubMed] [Google Scholar]
  5. Choo K. B., Pan C. C., Han S. H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology. 1987 Nov;161(1):259–261. doi: 10.1016/0042-6822(87)90195-4. [DOI] [PubMed] [Google Scholar]
  6. Cooper K., Herrington C. S., Graham A. K., Evans M. F., McGee J. O. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol. 1991 May;44(5):406–409. doi: 10.1136/jcp.44.5.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cooper K., Herrington C. S., Lo E. S., Evans M. F., McGee J. O. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol. 1992 May;45(5):382–384. doi: 10.1136/jcp.45.5.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cooper K., Herrington C. S., Stickland J. E., Evans M. F., McGee J. O. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol. 1991 Dec;44(12):990–996. doi: 10.1136/jcp.44.12.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooper K. Nonisotopic in situ hybridization in the detection of integrated HPV 16/18 in cervical cancers. Hum Pathol. 1996 Jul;27(7):745–745. doi: 10.1016/s0046-8177(96)90410-4. [DOI] [PubMed] [Google Scholar]
  10. Das B. C., Sharma J. K., Gopalakrishna V., Luthra U. K. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol. 1992 Sep;73(Pt 9):2327–2336. doi: 10.1099/0022-1317-73-9-2327. [DOI] [PubMed] [Google Scholar]
  11. Di Luca D., Caselli E., Monini P., Rotola A., Savioli A., Cassai E. Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region. Virus Res. 1989 Sep;14(1):49–55. doi: 10.1016/0168-1702(89)90068-3. [DOI] [PubMed] [Google Scholar]
  12. Dyson N., Howley P. M., Münger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989 Feb 17;243(4893):934–937. doi: 10.1126/science.2537532. [DOI] [PubMed] [Google Scholar]
  13. Herrington C. S. Control of HPV replication: implications for squamous neoplasia. J Pathol. 1996 Mar;178(3):237–238. doi: 10.1002/(SICI)1096-9896(199603)178:3<237::AID-PATH518>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  14. Herrington C. S. Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology. J Clin Pathol. 1994 Dec;47(12):1066–1072. doi: 10.1136/jcp.47.12.1066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Herrington C. S. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol. 1995 Jan;48(1):1–6. doi: 10.1136/jcp.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ho G. Y., Burk R. D., Klein S., Kadish A. S., Chang C. J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995 Sep 20;87(18):1365–1371. doi: 10.1093/jnci/87.18.1365. [DOI] [PubMed] [Google Scholar]
  17. Kataja V., Syrjänen K., Mäntyjärvi R., Väyrynen M., Syrjänen S., Saarikoski S., Parkkinen S., Yliskoski M., Salonen J. T., Castren O. Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol. 1989 Mar;5(1):1–7. doi: 10.1007/BF00145037. [DOI] [PubMed] [Google Scholar]
  18. Kataja V., Syrjänen K., Syrjänen S., Mäntyjärvi R., Yliskoski M., Saarikoski S., Salonen J. T. Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol. 1990 Mar;6(1):9–14. doi: 10.1007/BF00155542. [DOI] [PubMed] [Google Scholar]
  19. Koutsky L. A., Holmes K. K., Critchlow C. W., Stevens C. E., Paavonen J., Beckmann A. M., DeRouen T. A., Galloway D. A., Vernon D., Kiviat N. B. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992 Oct 29;327(18):1272–1278. doi: 10.1056/NEJM199210293271804. [DOI] [PubMed] [Google Scholar]
  20. Kristiansen E., Jenkins A., Holm R. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol. 1994 Mar;47(3):253–256. doi: 10.1136/jcp.47.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lehn H., Villa L. L., Marziona F., Hilgarth M., Hillemans H. G., Sauer G. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol. 1988 Jan;69(Pt 1):187–196. doi: 10.1099/0022-1317-69-1-187. [DOI] [PubMed] [Google Scholar]
  22. Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992 Mar;79(3):328–337. doi: 10.1097/00006250-199203000-00002. [DOI] [PubMed] [Google Scholar]
  23. Matlashewski G., Osborn K., Banks L., Stanley M., Crawford L. Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras. Int J Cancer. 1988 Aug 15;42(2):232–238. doi: 10.1002/ijc.2910420215. [DOI] [PubMed] [Google Scholar]
  24. Parkin D. M., Muir C. S. Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ. 1992;(120):45–173. [PubMed] [Google Scholar]
  25. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985 Mar 7;314(6006):111–114. doi: 10.1038/314111a0. [DOI] [PubMed] [Google Scholar]
  26. Sherman M. E., Schiffman M. H., Lorincz A. T., Manos M. M., Scott D. R., Kuman R. J., Kiviat N. B., Stoler M., Glass A. G., Rush B. B. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol. 1994 Aug;102(2):182–187. doi: 10.1093/ajcp/102.2.182. [DOI] [PubMed] [Google Scholar]
  27. Shirasawa H., Tomita Y., Kubota K., Kasai T., Sekiya S., Takamizawa H., Simizu B. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia. J Gen Virol. 1986 Sep;67(Pt 9):2011–2015. doi: 10.1099/0022-1317-67-9-2011. [DOI] [PubMed] [Google Scholar]
  28. Unger E. R., Vernon S. D., Thoms W. W., Nisenbaum R., Spann C. O., Horowitz I. R., Icenogle J. P., Reeves W. C. Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J Infect Dis. 1995 Nov;172(5):1184–1190. doi: 10.1093/infdis/172.5.1184. [DOI] [PubMed] [Google Scholar]
  29. Walboomers J. M., de Roda Husman A. M., Snijders P. J., Stel H. V., Risse E. K., Helmerhorst T. J., Voorhorst F. J., Meijer C. J. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol. 1995 Aug;48(8):728–732. doi: 10.1136/jcp.48.8.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990 Apr 6;248(4951):76–79. doi: 10.1126/science.2157286. [DOI] [PubMed] [Google Scholar]
  31. Woodman C. B., Rollason T., Ellis J., Tierney R., Wilson S., Young L. Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix. Br J Cancer. 1996 Feb;73(4):553–556. doi: 10.1038/bjc.1996.96. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES